SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Asset Entities, Inc. engages in providing social media marketing and content delivery services. It offers its services to Discord, TikTok, and other social media platforms. It also designs, develops and manages servers for communities on Discord. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani and Kyle Fairbanks on August 1, 2020 and is headquartered in Dallas, TX.

Asset Entities Inc - Ordinary Shares - Class B

Asset Entities Inc.

Asset Entities Inc. is trending due to the completion of its merger with Strive Enterprises, with the community anticipating a short squeeze and discussing the potential impact of the new CUSIP.  Bulls are excited about Strive's focus on Bitcoin investment and the possibility of a significant funding pipeline, while some traders highlight the high short interest and potential for dark pool manipulation. Chatter revolves around the potential for a substantial price increase and speculation about margin calls on Monday.

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Atyr Pharma Inc

aTyr Pharma, Inc

aTyr Pharma ($ATYR) is trending due to anticipation surrounding its upcoming Phase 3 data release for Efzofitimod, a treatment for pulmonary sarcoidosis. The community is actively discussing potential outcomes, with some speculating about leaked data and a possible short squeeze given the high short interest, while others are focused on the potential impact of positive results on the company's broader platform and future indications.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Gemini Space Station's IPO is trending amid volatile price action, sparking debates about IPO allocations and the influence of retail investors. The community is weighing the long-term potential against concerns over reported losses and the overall crypto market sentiment, while also comparing it to other recent IPOs. Some traders express excitement about potential gains, while others are wary of the stock's high valuation and the involvement of the Winklevoss twins.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending as investors anticipate significant catalysts, with community members closely watching for news of hyperscaler deals and a potential short squeeze. Optimism surrounds the company's AI infrastructure and data center prospects, especially after a key vote. Discussions include expectations for substantial growth and potential for the stock to become a long-term hold.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending due to regulatory approval for its acquisition of Oxford Ionics, sparking discussions about the company's future and potential advancements in quantum computing. Community members are actively debating the impact of the acquisition, potential catalysts, and the company's long-term prospects in a competitive sector. Some are drawing comparisons to other high-growth tech stocks.

Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. Its Fully Human Albumin Binding (FHAB) technology utilizes a single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its pipeline focuses on cytokines, a class of cell signaling peptides that, among other important functions, serve as potent immunomodulatory agents. The company was founded by Pankaj Mohan and John K. Cini in 2011 and is headquartered in Princeton, NJ.

Sonnet BioTherapeutics Holdings Inc

SONN is trending due to speculation surrounding a potential merger related to cryptocurrency, with community members pointing to a possible short squeeze given the stock's high short interest. Conversations revolve around predictions of a significant price increase and the potential impact of the merger on shareholder value. Some traders are actively shorting the stock, anticipating a price crash, while others remain bullish, drawing comparisons to similar stocks that have experienced substantial gains.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape ($QS) is trending as community members discuss the implications of its battery tech being demoed in a Ducati motorcycle at IAA Mobility. Investors are weighing positive developments, including potential partnerships, against concerns about timeline to revenue and cash burn. Discussions also involve speculation around potential OEM partners and the impact of solid-state battery technology on the broader EV market.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending due to a report that the Trump administration may link COVID-19 vaccines to child deaths, causing concern and prompting discussion about the reliance on unverified data. The community is debating the validity of the report and its potential impact on vaccine manufacturers, with some seeing it as a buying opportunity due to the high dividend yield and others expressing concerns about the company's future prospects amidst evolving views on vaccine safety. Some traders believe the stock will see increased volatility following the HHS leadership change and potential impact on vaccine policies.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the stock experiences a significant rally, with community members discussing potential price targets and the strength of bullish momentum. Some are attributing the rise to increased activity in call options, while others point to news regarding Tesla's energy business. The community is also weighing in on the potential impact of upcoming events and Elon Musk's involvement with the company.

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

GlucoTrack Inc

GCTK is trending due to a recent $20 million stock purchase agreement, sparking discussions of a potential short squeeze and comparisons to other high-flying stocks. Community members are actively debating the impact of this agreement and anticipating upcoming news from an investor summit. Some traders are expressing concerns about dilution, while others remain optimistic about the company's long-term potential in the glucose monitoring market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$VKTX $IBB $LLY  
 
The problem the shorts have is seen in the chart below. And it is purely technical. If VKTX takes out $26.70ish, there is a quick path to just under $30 - just to fill that gap. The reason I feel this is more likely than not is because of the fact that the results were actually really good. That can&amp;#39;t be denied. Had they pooped the bed, it would be a different story. But the dose that actually matters looks like it may actually be best in class. Now, I point you to the volume the last two day. It was monster volume. But almost all of that volume took place in a tight range, not as the stock was declining. That is indication of accumulation. Accumulating for what? Well, bigger and better things ahead. I think shorts are playing with fire on this one. We will know by beginning/middle of next week after the accumulation period ends.

svk33

Sue vin

Dante

Wallace Rico

scott burdette

StockTwits For Android 

Viking Therapeutics Inc

iShares Biotechnology ETF

Lilly(Eli) & Co

  
 
The problem the shorts have is seen in the chart below. And it is purely technical. If VKTX takes out $26.70ish, there is a quick path to just under $30 - just to fill that gap. The reason I feel this is more likely than not is because of the fact that the results were actually really good. That can&#39;t be denied. Had they pooped the bed, it would be a different story. But the dose that actually matters looks like it may actually be best in class. Now, I point you to the volume the last two day. It was monster volume. But almost all of that volume took place in a tight range, not as the stock was declining. That is indication of accumulation. Accumulating for what? Well, bigger and better things ahead. I think shorts are playing with fire on this one. We will know by beginning/middle of next week after the accumulation period ends.